IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced the appointment of Paul Bae as Vice President of Human Resources, reporting to Kathy McGinley, Aerie’s Vice President of Human Resources and Corporate Services. Mr. Bae will be responsible for leading the strategic hum
Category: Business
Global Ocular Drug Delivery Technology Market to 2025 by Technology, Indication & Geography – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Ocular Drug Delivery Technology Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to Research an…
Dr. John J. Kownacki, Ophthalmologist, Joins Trilogy Eye Medical Group (Acuity Eye Group™)
PASADENA, Calif. & SAN DIEGO–(BUSINESS WIRE)–Dr. John J. Kownacki, Ophthalmologist, joins Trilogy Eye Medical Group (Acuity Eye Group™).
Aenitis Technologies Receives €4 Million in Funding from the European H2020 / SME Instrument Programme, for Its ABC-S’ Project (Acoustic Blood Cell Sorter)
PARIS–(BUSINESS WIRE)–Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industri
Glaukos Announces Issuance of New U.S. Patent
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9,827,143 to the company. Entitled “Shunt Device and Method for Treating Ocular Disorders”, the newly issued patent covers ocular devices and methods of
Global Bacterial Conjunctivitis Market 2017-2025 – $436.7 Million Application Analysis, Growth Trends & Key Players – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Global Bacterial Conjunctivitis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to Research and Marke…
Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics Corporation (Ambry), a leading clinical genetics-testing lab, recently published a paper concerning mutations in the FDXR gene, detailing how a team of researchers completed an entire diagnostic journey – from novel gene identification to potential treatment development; offering hope of a treatment to patients with vision loss due to mitochondrial disease. The paper, Biallelic mutations in the ferredoxin reductase gene cause novel mitochondr
Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics Corporation (Ambry), a leading clinical genetics-testing lab, recently published a paper concerning mutations in the FDXR gene, detailing how a team of researchers completed an entire diagnostic journey – from novel gene identification to potential treatment development; offering hope of a treatment to patients with vision loss due to mitochondrial disease. The paper, Biallelic mutations in the ferredoxin reductase gene cause novel mitochondr
ReVision Optics’ Raindrop Near Vision Inlay Featured in Presentations and Instructional Sessions at the American Academy of Ophthalmology Annual Meeting
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc. (RVO), a leader in implantable presbyopia-correcting corneal inlay technology, announces that its Raindrop® Near Vision Inlay for presbyopia was featured in multiple scientific presentations and instructional courses at the annual meeting of the American Academy of Ophthalmology (AAO) held November 11-14 in New Orleans. The presentations highlighted study data focusing on key attributes to improve clinical outcomes with the Raindrop pr
ReVision Optics’ Raindrop Near Vision Inlay Featured in Presentations and Instructional Sessions at the American Academy of Ophthalmology Annual Meeting
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc. (RVO), a leader in implantable presbyopia-correcting corneal inlay technology, announces that its Raindrop® Near Vision Inlay for presbyopia was featured in multiple scientific presentations and instructional courses at the annual meeting of the American Academy of Ophthalmology (AAO) held November 11-14 in New Orleans. The presentations highlighted study data focusing on key attributes to improve clinical outcomes with the Raindrop pr
Top 3 Drivers for Global Photochromic Lenses Market | Technavio
LONDON–(BUSINESS WIRE)–#Health–Technavio market research analysts forecast the global photochromic lenses market to grow at a CAGR of close to 3% during the period 2017-2021.
Global Ophthalmic Therapeutics/Drug Market Analysis 2014-2017 & Forecasts to 2025 By Class, Disease And Segment Forecasts – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Therapeutics/Drug Market Analysis By Class (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis), And Segment Foreca…
Global Ocular Implants (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Ocular Prosthesis) Market Analysis, 2014 – 2025 – Research and Markets
DUBLIN–(BUSINESS WIRE)–The “Ocular Implants Market Analysis By Product (Intraocular Lenses, Corneal Implants, Glaucoma Implants, Ocular Prosthesis), By Application (Glaucoma, Drug Delivery), By End-use, And Segment Forecasts, 2014 – 2025” report has …
PogoTec Files Form 1-A with the SEC to Launch a Regulation A+ IPO
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–PogoTec, Inc., an innovator in wearable devices, today announced that on November 16, 2017, it filed an Offering Statement on Form 1-A with the Securities and Exchange Commission (“SEC”) to launch a Regulation A+ initial public offering (“IPO”). This filing came on the same day the company announced the purchase availability of PogoCam, the world’s smallest and lightest attachable eyewear camera that unobtrusively attaches to virtually all eyewear so cons
Universal Diagnostics Starts Clinical Study of Novel Blood Screening Test for Early Detection of Colon Cancer with Imperial College Healthcare NHS Trust
SEVILLE, Spain & LONDON–(BUSINESS WIRE)–Universal Diagnostics started a clinical study of its colorectal screening blood test in collaboration with Imperial College Healthcare NHS Trust
ソウル半導体、自然光LEDの”SunLike”で世界初の高いアイセーフティ認証
韓国安山市–(BUSINESS WIRE)–（ビジネスワイヤ） — 世界的なLED （発光ダイオード）専業メーカーのSeoul Semiconductor Co., Ltd. (本社：韓国安山市、代表理事：李貞勲、以下「ソウル半導体」)は、太陽の光に最も近い光を発するLEDの”SunLike”が、光源の安全性に関するアイセーフティ認証でRG-1の評価を受け、最高レベルの安全性が認められたと明らかにした。 アイセーフティ認証は、LEDから発せられる波長を分析して、安全性に基づいて等級分けされる認証である。照明の安全性の優先度が非常に高い欧州地域では、アイセーフティ認証が不可欠であり、目で直接見たときに、視力に危険を及ぼす可能性のあるリスクグループ3 (RG-3)以下の光源については、完成品に警告文を記述することを義務化している。 SunLikeは、東芝マテリアル株式会社(本社：神奈川県横浜市、代表取締役社長：青木 克明)のTRI-R技術を応用した自然光LEDで、このたびアイセーフティ認証でRG-1の等級を受けた。 RG-1は、当該光源の下で一生生活を続けても生体学的な危険がない安
GEBA Plans Now Available to All Federal Civilian Employees
FORT MEADE, Md.–(BUSINESS WIRE)–The non-profit Government Employees’ Benefit Association (GEBA) expands to now serve all federal civilian employees and retirees.
NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for lid and lash hygiene in the domestic eye care market, reports financial results for the three and ninth months ended September 30, 2017 and provides a business update. “First off, we are significantly better positioned to support continued Avenova growth having entered into a $10.3 million financing with accredited investors
Aerpio Pharmaceuticals Announces Appointment of Michael Rogers as Chief Financial Officer
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced today that Michael Rogers has been appointed Chief Financial Officer effe…
Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals announced the appointment of Todd Bazemore as Chief Operating Officer of the Company.